Back to Trades
Grant4
VERTEX PHARMACEUTICALS INC / MA
VRTX
Total Value
$608.2K
Company Information
- Company Name
- VERTEX PHARMACEUTICALS INC / MA
- Ticker Symbol
- VRTX
- CIK
- 0000875320
Insider Information
- Name
- Thornberry Nancy
- Role
- Director
- Location
- BOSTON, MA
Director
Filing Details
- Filing Date
- May 5, 2026
- Transaction Date
- May 1, 2026
- Accession Number
- 0000875320-26-000191
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | 472 | — | Grant/Award | — |
| May 1, 2026 | Common Stock | 398 | — | Disposition | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 1, 2026 | Derivative | 1,433 | $424.45 | Grant/Award | $608.2K |
| May 1, 2026 | Derivative | 398 | — | Grant/Award | — |
Footnotes
- (F1)Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
- (F2)Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units.
- (F3)Fully vested.
- (F4)Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death.